Trip.com Faces Securities Investigation Following Antitrust Probe and Stock Decline

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Trip.com faces securities investigation after Chinese antitrust probe triggered 17% stock decline. Law firm evaluates potential shareholder losses from alleged misleading disclosures.

Trip.com Faces Securities Investigation Following Antitrust Probe and Stock Decline

The Rosen Law Firm has initiated an investigation into potential securities claims against Trip.com Group Limited (NASDAQ: TCOM) following a regulatory action by Chinese authorities. On January 14, 2026, Trip.com's stock experienced a significant decline of 17 percent after the company disclosed that it had become the subject of an antitrust probe by Chinese regulators.

The investigation centers on allegations that Trip.com may have provided misleading information to investors regarding its business operations and regulatory compliance status. The law firm is evaluating whether shareholders experienced losses due to material misstatements or omissions by the company prior to the antitrust disclosure.

Investors who held Trip.com securities during the relevant period and sustained losses are being encouraged to contact the firm to discuss potential remedies. The investigation may lead to the formation of a class action lawsuit seeking to recover damages on behalf of affected shareholders.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 27

Related Coverage

GlobeNewswire Inc.

Gemini Space Station Faces Class Action Lawsuit Over IPO Misstatements

Class action lawsuit filed against Gemini Space Station for alleged IPO misstatements regarding crypto platform viability and international expansion. Application deadline: May 18, 2026.

ENPHGEMI
GlobeNewswire Inc.

Enphase Energy Faces Securities Fraud Lawsuit Over Undisclosed Channel Inventory Issues

Class action lawsuit filed against $ENPH alleges securities fraud over channel inventory management and Clean Energy Credit disclosure failures. Deadline for lead plaintiff claims: April 20, 2026.

ENPH
GlobeNewswire Inc.

Immutep Stock Plummets 82.6% After Failed Phase III Trial, Sparking Lawsuit

Immutep's $IMMP stock crashed following discontinued Phase III trial for eftilagimod alfa. Rosen Law Firm launches investigation into potential securities claims and class action lawsuit.

IMMP
Benzinga

Alight Securities Fraud Lawsuit Opens: Investors Sought for Class Action Over False Claims

Schall Law Firm seeks investors in $ALIT securities fraud class action, alleging false statements about operations, dividends, and expenses.

ALIT
GlobeNewswire Inc.

Lufax Investors Face May 2026 Deadline in Securities Fraud Class Action

Rosen Law Firm filed securities class action against $LU alleging false statements on internal controls and financials. Investors have until May 20, 2026 to claim lead plaintiff status.

LU
GlobeNewswire Inc.

Inovio Investors Face April 7 Deadline in Securities Class Action Over Alleged Misstatements

Rosen Law Firm alerts $INO investors of April 7, 2026 deadline to join class action over alleged false statements regarding manufacturing and regulatory prospects.

INO